Chemoinformaics analysis of Spinacetin-3-0-Rhamnoglucoside
Molecular Weight | 654.574 | nRot | 8 |
Heavy Atom Molecular Weight | 620.302 | nRig | 30 |
Exact Molecular Weight | 654.18 | nRing | 5 |
Solubility: LogS | -2.386 | nHRing | 3 |
Solubility: LogP | 0.251 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 46 | No. of Aromatic Carbocycles | 2 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
nHA | 17 | APOL | 84.735 |
nHD | 9 | BPOL | 47.129 |
QED | 0.135 |
Synth | 4.849 |
Natural Product Likeliness | 1.921 |
NR-PPAR-gamma | 0.105 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.007 |
Pgp-sub | 0.998 |
HIA | 0.829 |
CACO-2 | -6.458 |
MDCK | 0.000029 |
BBB | 0.065 |
PPB | 0.769012 |
VDSS | 0.624 |
FU | 0.246861 |
CYP1A2-inh | 0.045 |
CYP1A2-sub | 0.626 |
CYP2c19-inh | 0.024 |
CYP2c19-sub | 0.065 |
CYP2c9-inh | 0.009 |
CYP2c9-sub | 0.146 |
CYP2d6-inh | 0.03 |
CYP2d6-sub | 0.14 |
CYP3a4-inh | 0.036 |
CYP3a4-sub | 0.007 |
CL | 1.831 |
T12 | 0.781 |
hERG | 0.283 |
Ames | 0.786 |
ROA | 0.037 |
SkinSen | 0.556 |
Carcinogencity | 0.063 |
EI | 0.224 |
Respiratory | 0.027 |
NR-Aromatase | 0.851 |
Antiviral | Yes |
Prediction | 0.753416 |